YK-4-279 was initially reported as a small molecule targeting the interaction of oncogenic protein EWS-FLI1 with RNA helicases DHX9 and DDX5 in Ewing’s sarcoma (23). This evidence concerns the gene PROS1 and Ewing sarcoma.